Molecular Identification of Extrapulmonary Vaccine Adverse Events after BCG in Paraffin-Embedded Specimens

Molecular Identification of Extrapulmonary Vaccine Adverse Events after BCG in Paraffin-Embedded Specimens

According to the World Health Organization (WHO), around 1 million children worldwide are diagnosed with tuberculosis each year. The Bacillus Calmette–Guérin (BCG) vaccine has been used around the world for over 100 years. The complications of the BCG vaccination can occur in about 0,06% of children...

Full description

Bibliographic Details
Main Authors:	Sylwia Brzezińska, Anna Zabost, Dagmara Borkowska-Tatar, Magdalena Klatt, Jolanta Goździk, Agnieszka Dłużniewska, Katarzyna Błasińska, Ewa Augustynowicz-Kopeć
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	Pathogens
Subjects:	<i>Mycobacterium bovis</i> BCG genetic test granulomas histopathological specimens
Online Access:	https://www.mdpi.com/2076-0817/12/12/1374

Similar Items

Histopathologic differences in granulomas of Mycobacterium bovis bacille Calmette Guérin (BCG) vaccinated and non-vaccinated cattle with bovine tuberculosis
by: C. Kanipe, et al.
Published: (2022-11-01)

A case of infectious endocarditis due to BCG
by: Alice Fournier, et al.
Published: (2015-06-01)

Protective Efficacy of BCG Vaccination in Calves Vaccinated at Different Ages
by: Jayne C. Hope, et al.
Published: (2023-05-01)

Local Lung Immune Response to <i>Mycobacterium bovis</i> Challenge after BCG and <i>M. bovis</i> Heat-Inactivated Vaccination in European Badger (<i>Meles meles</i>)
by: Cristina Blanco Vázquez, et al.
Published: (2020-06-01)

Harnessing <i>Mycobacterium bovis</i> BCG Trained Immunity to Control Human and Bovine Babesiosis
by: Reginaldo G. Bastos, et al.
Published: (2022-01-01)

Vascular graft infections caused by Mycobacterium bovis BCG after BCG immunotherapy for non-muscle-invasive bladder cancer: Case report and review of literature
by: Stefania Arsuffi, et al.
Published: (2023-05-01)

Molecular analysis of Mycobacterium isolates from patients with BCG-induced lymphadenitis
by: Farahnoosh Doustdar, et al.
Published: (2015-01-01)

<i>Mycobacterium bovis</i> Transmission between Cattle and a Farmer in Central Poland
by: Monika Krajewska-Wędzina, et al.
Published: (2022-10-01)

Vaccination-related Mycobacterium bovis BCG Infection
by: Anna Liberek, et al.
Published: (2006-05-01)

A case of disseminated M. bovis bacillus Calmette-Guérin (BCG) disease after one month of BCG bladder infusion therapy and analysis of 77 cases of suspected BCG infection in Japan, 2017–2022
by: Masashi Nishimura, et al.
Published: (2023-01-01)

Time to face the proofs: the BCG Moreau vaccine promotes superior inflammatory cytokine profile in vitro when compared with Russia, Pasteur, and Danish strains
by: Andreon Santos Machado da Silva, et al.
Published: (2022-01-01)

Grupo Técnico de Estudos do BCG em Câncer Vacina BCG (Bacillus Calmette-Guérin)
by: Humberto Torloni, et al.
Published: (2023-08-01)

Impact of Genomic Deletion RD16 on the Expression of the <i>Mycobacterium bovis</i> BCG Moreau VapBC47 Toxin-Antitoxin System
by: Talita Duarte Pagani, et al.
Published: (2023-08-01)

Phosphate starvation enhances phagocytosis of Mycobacterium bovis/BCG by macrophages
by: Patricia Espinosa-Cueto, et al.
Published: (2020-06-01)

Advances in the characterization of a proteol iposome derived from Mycobacterium bovis BCG as vaccine candidate against tuberculosis
by: Nadine Alvarez-Cabrera, et al.
Published: (2014-12-01)

The double-edged sword - prosthetic joint infection following BCG treatment for bladder cancer: a case report
by: Minh-Vu Hoang Nguyen, et al.
Published: (2019-04-01)

[Fever of Unknown Origin in a Patient Administered With Bacillus Calmette-Guérin (BCG) to Treat Urothelial Vesical Carcinoma in Situ]
by: Paolo Ghiringhelli, et al.
Published: (2023-07-01)

Evolução das lesões induzidas por micobactérias BCG e por H37RV em hamster (Mesocricetus auratus)
by: Eliana Roxo, et al.
Published: (1994-11-01)

Extracellular forms of Mycobacterium bovis BCG in the mucosal lymphatic tissues following oral vaccination
by: Wenzel Czepluch, et al.
Published: (2013-01-01)

Osteomielitis esternal y escrofuloderma por vacuna BCG.
by: Ivohne Fernanda Corrales, et al.
Published: (2003-06-01)

Mycobacterium bovis BCG: the importance of an accurate identification in the diagnostic routine
by: Antonella Grottola, et al.
Published: (2010-09-01)

Culture-proven disseminated Mycobacterium Bovis infection (BCG-Osis) following intravesical BCG immunotherapy in a patient with bladder carcinoma-in-situ: ‘Case report’
by: Ahmed Ghonaimy, et al.
Published: (2022-02-01)

M. BOVIS BCG-1 (RUSSIA) SUB-STRAIN GENOME STABILITY INVESTIGATION WITHIN THE ENTIRE PRODUCTION PROCESS
by: E. V. Otrashevskaya, et al.
Published: (2018-04-01)

The Antibacterial Effect of <i>Humulus lupulus</i> (Hops) against <i>Mycobacterium bovis</i> BCG: A Promising Alternative in the Fight against Bovine Tuberculosis?
by: James Blaxland, et al.
Published: (2022-07-01)

Prime Vaccination with Chitosan-Coated Phipps BCG and Boosting with CFP-PLGA against Tuberculosis in a Goat Model
by: Yesenia Guadalupe Contreras-Magallanes, et al.
Published: (2021-04-01)

DosR’s multifaceted role on Mycobacterium bovis BCG revealed through multi-omics
by: Yingying Cui, et al.
Published: (2023-11-01)

Transcriptional Profiling of Homologous Recombination Pathway Genes in <i>Mycobacterium bovis</i> BCG Moreau
by: Marcos Gustavo Araujo Schwarz, et al.
Published: (2023-10-01)

Sporotrichoid distributed tuberculous panniculitis as a late complication of intravesical bacillus Calmette–Guérin (BCG) immunotherapy
by: Nina Nielens, et al.
Published: (2022-04-01)

Empleo de una PCR-multiplex para diferenciar caprinos vacunados con M. bovis BCG de infectados con M. bovis de campo
by: Isaura Carolina Ramírez Casillas, et al.
Published: (2012-01-01)

First insight into the whole-genome sequence variations in Mycobacterium bovis BCG-1 (Russia) vaccine seed lots and their progeny clinical isolates from children with BCG-induced adverse events
by: Olga Narvskaya, et al.
Published: (2020-08-01)

Mechanisms of cell accumulation induced by Mycobacterium bovis BCG
by: Octávio Menezes-de-Lima-Júnior, et al.
Published: (1997-12-01)

BCG: the only available vaccine against tuberculosis: review article
by: Roghayeh Teimourpour, et al.
Published: (2017-01-01)

Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
by: Suleiman Al-Hammadi, et al.
Published: (2017-05-01)

A single strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG) grown in two different media evokes distinct humoral immune responses in mice
by: V.L. Petricevich, et al.
Published: (2001-01-01)

Activation dynamics of antigen presenting cells in vivo against Mycobacterium bovis BCG in different immunized route
by: Zhengzhong Xu, et al.
Published: (2023-11-01)

Human Properdin Modulates Macrophage: Mycobacterium bovis BCG Interaction via Thrombospondin Repeats 4 and 5
by: Maha Ahmed Al-Mozaini, et al.
Published: (2018-05-01)

Doença de Pott após tratamento intravesical com Mycobacterium bovis BCG
by: Samaher Tannira, et al.
Published: (2016-03-01)

Telacebec Interferes with Virulence Lipid Biosynthesis Protein Expression and Sensitizes to Other Antibiotics
by: Zhiyu Zhou, et al.
Published: (2023-09-01)

Enhanced immunogenicity of Mycobacterium bovis BCG through CRISPRi mediated depletion of AftC
by: Bala T.S.A. Madduri, et al.
Published: (2022-12-01)

BCG and SARS-CoV-2—What Have We Learned?
by: Jakub Kulesza, et al.
Published: (2022-09-01)